US Wants COVID-19 Vaccine Booster Doses at 8 Months
The Biden administration reportedly hopes for FDA-authorized booster doses for the adult general population in the next month.
How Soon Will COVID-19 Vaccine Booster Doses Be Available in the US?
The US is targeting a possible Fall rollout of publicly available doses, yet experts debate their current necessity.
What COVID-19 Vaccine Booster Doses Mean for the Pandemic
Donald Alcendor, PhD, shares expert perspective on the newest FDA authorization, as well as what a full COVID-19 vaccine approval would mean for US immunization.
FDA Permits Third COVID-19 Vaccine Dose for Immunocompromised People
The move will offer an extra boost of immunity for patients with compromised immune systems, including organ transplant recipients.
Two-Dose COVID-19 Vaccines Remain Effective Versus Delta Variant
An England study shows the Pfizer-BioNTech and AstraZeneca vaccines remain effective in reducing symptomatic disease risk.
FDA Plans to Authorize COVID-19 Vaccine Booster Doses for Immunocompromised Patients
Emergency authorization may be complete before the end of August, ensuring more protection for patients burdened with certain chronic diseases.
Novavax COVID-19 Vaccine Booster Provides 6-Fold Delta Variant Antibodies
The report of promising phase 2 findings align with word that an FDA submission will be delayed until later this year.
Is There Risk of Flu Outbreaks in the 2021-22 Season?
Last influenza season was notably quiet during peaking COVID-19 cases. Experts explain what may influence risk of dueling epidemics this year.
FDA Approves Pneumococcal 15-Valent Conjugate Vaccine for US Adults
The prophylaxis showed non-inferiority across shared serotypes with an available 13-valent vaccine in its indication-supporting data.
FDA Grants Priority Review to Pfizer-BioNTech COVID-19 Vaccine
The designation moves the companies' PDUFA date up to January 2022, when BNT162b2 may become the first regulated COVID-19 vaccine.
How Do You Measure the Success of Your Stewardship Program?
The challenging search for a metric that effectively evaluates an ASP’s direct impact on appropriate antimicrobial use and improved patient outcomes.
Novavax COVID-19 Vaccine Provides 90% Efficacy, Will Submit for Regulation
Experts suggest the vaccine, if regulated by the FDA, would benefit the US as a booster dose to combat waning immunity against emerging variants.
Antimicrobials Frequently Prescribed in Hospitalized COVID-19 Patients
A prospective study suggest co-infections and secondary infections are infrequent among COVID-19 patients, warranting the need for improved stewardship.
Serum PCT Provides Antibiotic Prescribing Strategies for COVID-19
New research from Emory show a significant difference in institutional antibiotic prescribing after education on the value of PCT testing in infected patients last year.
Pfizer-BioNTech COVID-19 Vaccine Achieves 100% Effectiveness in Adolescents
The newest data for the real-world assessment show the mRNA vaccine provides greater immunogenicity in persons aged 12-15 years old than in young adults.
Dengue Vaccine Candidate Provides 62% Efficacy for Children & Adolescents at 3 Years
TAK-003, from Takeda, is showing slightly improved protection among seropositive participants through its 36-month follow-up.
Shorter Prescription Stop Dates Do Not Influence Antibiotic Treatment Duration
An effort to increase stewardship showed that 5-day and 10-day prescription stop dates for antibiotics did little to influence actual therapy length and outcomes.
Antibiotic Prescribing, Guideline Adherence May Vary by Care Setting
An assessment from the Cleveland Clinic shows prescribing concordant to guidelines can exceed 60% in certain facilities.
Pharmacist-Led Flu Shot Screening Leads to Improved Community Immunization
A concerted effort to increase flu vaccination during the COVID-19 pandemic resulted in more protection among a high-risk population, as well as educational opportunities for pharmacy students.
Strategies to Address COVID-19 Vaccine Hesitancy Among Minority Communities
Discriminately affected populations face a wall of hurdles, historic and contextual, in buying into COVID-19 vaccine benefit. What can clinicians and public health officials do to help?
FDA Expands Pfizer-BioNTech COVID-19 Vaccine for Adolescents 12-15 Years Old
The first US COVID-19 vaccine breaks ground again, as the first authorized for patients as young as 12 years old.
Pfizer-BioNTech COVID-19 Vaccine Significantly Prevents Infection, Severe Disease in Israel
New real-world research suggest the vaccine may help provide control of the pandemic virus.
Novavax Initiates Pediatric, Adolescent COVID-19 Vaccine Study
A treatment arm of up to 3000 participants aged 12-17 years old will be rolled into the North American-based PREVENT-19 trial.
COVID-19 Vaccines Do Not Significantly Influence Pregnancy Outcomes, Preliminary Study Shows
New analysis of registry data suggest pregnant persons are not facing particularly worse pregnancy nor neonatal outcomes after mRNA vaccination.
Antimicrobial Stewardship Can Help Prevent Injection Drug Use–Related Infections
Escalating usage and more drug choices are putting more people at risk.
Do β-Lactam Prolonged Infusions Suppress the Emergence of Resistance?
This approach can help with clinical outcomes and mortality, but resistance is not as well defined.
Molecular Diagnostics for Bacterial Pneumonia Need Testing Stewardship
Ongoing education and proven outcomes need to aid this form of testing.
BNT162b2: The First COVID-19 Vaccine
FDA, CDC Pause Johnson & Johnson COVID-19 Vaccine After 6 Cerebral Venous Thrombosis Cases
The federal agencies will advise states withhold administration of the Johnson & Johnson one-shot product while investigating risk of a rare blood clot disorder.
Let’s Say It Out Loud: Being Vaccinated Has Benefits
Our editor-in-chief writes on the role caregivers play in informing the public on the perks of a more vaccinated population.
2 Clarke Drive Cranbury, NJ 08512